Danica Grujičić

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp, Monika E. Hegi, Thierry Gorlia et al. · The Lancet Oncology · 2014 · 1K citations

Neuro-oncology, Glioma, Medicine +9

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa et al. · The Lancet Oncology · 2021 · 280 citations · Full text

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

Burt Nabors, Karen Fink, Tom Mikkelsen et al. · Neuro-Oncology · 2015 · 231 citations · Full text

Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach

Branislav Jeremić, Danica Grujičić, Vaso Antunović et al. · Journal of Neuro-Oncology · 1994 · 122 citations

Neuro-oncology, Surgical Oncology, Glioblastoma Multiforme +11

Nerve transfer in brachial plexus traction injuries

Miroslav Samardžić, Danica Grujičić, Vaso Antunović · Journal of neurosurgery · 1992 · 114 citations

Spinal Cord Injury, Peripheral Nerve Injury, Brachial Plexus Palsy +13